Coffee and Alzheimer's Disease: Reviewing the Neuroprotective Effects of Bioactive Compounds
DOI:
https://doi.org/10.12775/QS.2024.29.55649Keywords
Alzheimer disease, coffee, caffeine, chlorogenic acid, quercetin, trigonelline, caffeic acid, kaempferol, neuroprotectiveAbstract
Alzheimer's disease (AD) is a common neurodegenerative disorder primarily managed with symptomatic treatments. Coffee, a popular beverage, contains bioactive compounds like caffeine, chlorogenic acid, quercetin, trigonelline, caffeic acid, and kaempferol, which may offer neuroprotective benefits. These compounds could potentially address AD-related pathologies such as amyloid-beta accumulation, tau hyperphosphorylation, oxidative stress, and inflammation. This review explores the neuroprotective potential of coffee's bioactive components in AD.
Aim of the Study
This study aims to review research on the neuroprotective effects of coffee and its bioactive compounds in Alzheimer's disease. It seeks to understand how these compounds may mitigate AD-related pathologies and their potential in preventive and therapeutic applications. The study also identifies knowledge gaps and suggests future research directions.
Material and Methods
We reviewed literature from PubMed, Google Scholar and other scientific sources using keywords: Alzheimer's disease, coffee, neuroprotective, caffeine, chlorogenic acid, quercetin, trigonelline, caffeic acid, and kaempferol.
Conclusions
Emerging evidence indicates that coffee's bioactive compounds may offer neuroprotective benefits against Alzheimer's disease. Compounds such as caffeine, chlorogenic acid, quercetin, trigonelline, caffeic acid, and kaempferol show potential in mitigating key AD pathologies. However, the current evidence is preliminary, and more research is needed to fully understand their cognitive benefits and mechanisms. Investigating these properties is particularly relevant given the aging global population and the age-related nature of AD.
References
DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener. 2019 Aug 2;14(1):32. doi: 10.1186/s13024-019-0333-5. PMID: 31375134; PMCID: PMC6679484.
Kumar A, Sidhu J, Lui F, Tsao JW, Doerr C. Alzheimer Disease (Nursing). 2024 Feb 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 33760564.
2023 Alzheimer's disease facts and figures. Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14. PMID: 36918389.
Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG. Alzheimer's disease: risk factors and potentially protective measures. J Biomed Sci. 2019 May 9;26(1):33. doi: 10.1186/s12929-019-0524-y. PMID: 31072403; PMCID: PMC6507104.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM. Alzheimer's disease. Lancet. 2021 Apr 24;397(10284):1577-1590. doi: 10.1016/S0140-6736(20)32205-4. Epub 2021 Mar 2. PMID: 33667416; PMCID: PMC8354300.
Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789. PMID: 33302541; PMCID: PMC7764106.
Samoggia A, Riedel B. Consumers' Perceptions of Coffee Health Benefits and Motives for Coffee Consumption and Purchasing. Nutrients. 2019 Mar 18;11(3):653. doi: 10.3390/nu11030653. PMID: 30889887; PMCID: PMC6471209.
Perszke Michał, Egierska Dominika. Potential health benefits from coffee consumption. Journal of Education, Health and Sport. 2022;12(10):11-18. eISSN 2391-8306.
O'Keefe JH, DiNicolantonio JJ, Lavie CJ. Coffee for Cardioprotection and Longevity. Prog Cardiovasc Dis. 2018 May-Jun;61(1):38-42. doi: 10.1016/j.pcad.2018.02.002. Epub 2018 Feb 21. PMID: 29474816.
Socała K, Szopa A, Serefko A, Poleszak E, Wlaź P. Neuroprotective Effects of Coffee Bioactive Compounds: A Review. Int J Mol Sci. 2020 Dec 24;22(1):107. doi: 10.3390/ijms22010107. PMID: 33374338; PMCID: PMC7795778.
Cunha RA, Agostinho PM. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J Alzheimers Dis. 2010;20 Suppl 1:S95-116. doi: 10.3233/JAD-2010-1408. PMID: 20182043.
Merighi S, Travagli A, Nigro M, Pasquini S, Cappello M, Contri C, Varani K, Vincenzi F, Borea PA, Gessi S. Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? Biomolecules. 2023 Jun 8;13(6):967. doi: 10.3390/biom13060967. PMID: 37371547; PMCID: PMC10296091.
Fernandes MYD, Dobrachinski F, Silva HB, Lopes JP, Gonçalves FQ, Soares FAA, Porciúncula LO, Andrade GM, Cunha RA, Tomé AR. Neuromodulation and neuroprotective effects of chlorogenic acids in excitatory synapses of mouse hippocampal slices. Sci Rep. 2021 May 18;11(1):10488. doi: 10.1038/s41598-021-89964-0. PMID: 34006978; PMCID: PMC8131611.
Zhou X, Zhang L. The Neuroprotective Effects of Moderate and Regular Caffeine Consumption in Alzheimer's Disease. Oxid Med Cell Longev. 2021 Aug 17;2021:5568011. doi: 10.1155/2021/5568011. PMID: 34447487; PMCID: PMC8384510.
Zidan NS, Omran AME, Rezk SM, Atteia HH, Sakran MI. Anti-Alzheimer's disease potential of Arabian coffee versus Date palm seed extract in male rats. J Food Biochem. 2022 Jan;46(1):e14017. doi: 10.1111/jfbc.14017. Epub 2021 Nov 23. PMID: 34816451.
Trinh K, Andrews L, Krause J, Hanak T, Lee D, Gelb M, Pallanck L. Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism. J Neurosci. 2010 Apr 21;30(16):5525-32. doi: 10.1523/JNEUROSCI.4777-09.2010. PMID: 20410106; PMCID: PMC3842467.
Taram F, Winter AN, Linseman DA. Neuroprotection comparison of chlorogenic acid and its metabolites against mechanistically distinct cell death-inducing agents in cultured cerebellar granule neurons. Brain Res. 2016 Oct 1;1648(Pt A):69-80. doi: 10.1016/j.brainres.2016.07.028. Epub 2016 Jul 18. PMID: 27444557.
Cho ES, Jang YJ, Hwang MK, Kang NJ, Lee KW, Lee HJ. Attenuation of oxidative neuronal cell death by coffee phenolic phytochemicals. Mutat Res. 2009 Feb 10;661(1-2):18-24. doi: 10.1016/j.mrfmmm.2008.10.021. Epub 2008 Nov 5. PMID: 19028509.
Mancini RS, Wang Y, Weaver DF. Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation. Front Neurosci. 2018 Oct 12;12:735. doi: 10.3389/fnins.2018.00735. PMID: 30369868; PMCID: PMC6194148.
Khan H, Ullah H, Aschner M, Cheang WS, Akkol EK. Neuroprotective Effects of Quercetin in Alzheimer's Disease. Biomolecules. 2019 Dec 30;10(1):59. doi: 10.3390/biom10010059. PMID: 31905923; PMCID: PMC7023116
Lee M, McGeer EG, McGeer PL. Quercetin, not caffeine, is a major neuroprotective component in coffee. Neurobiol Aging. 2016 Oct;46:113-23. doi: 10.1016/j.neurobiolaging.2016.06.015. Epub 2016 Jul 5. PMID: 27479153.
Carreiro EP, Costa AR, Antunes CM, Ernesto S, Pinto F, Rodrigues B, Burke AJ. Quercetin-1,2,3-Triazole Hybrids as Multifunctional Anti-Alzheimer's Agents. Molecules. 2023 Nov 9;28(22):7495. doi: 10.3390/molecules28227495. PMID: 38005217; PMCID: PMC10673615.
Ludwig IA, Clifford MN, Lean ME, Ashihara H, Crozier A. Coffee: biochemistry and potential impact on health. Food Funct. 2014 Aug;5(8):1695-717. doi: 10.1039/c4fo00042k. PMID: 24671262.
Fahanik-Babaei J, Baluchnejadmojarad T, Nikbakht F, Roghani M. Trigonelline protects hippocampus against intracerebral Aβ(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms. Metab Brain Dis. 2019 Feb;34(1):191-201. doi: 10.1007/s11011-018-0338-8. Epub 2018 Nov 12. PMID: 30421246.
Chowdhury AA, Gawali NB, Munshi R, Juvekar AR. Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice. Metab Brain Dis. 2018 Jun;33(3):681-691. doi: 10.1007/s11011-017-0147-5. Epub 2017 Dec 26. PMID: 29277879.
Pavlíková N. Caffeic Acid and Diseases-Mechanisms of Action. Int J Mol Sci. 2022 Dec 29;24(1):588. doi: 10.3390/ijms24010588. PMID: 36614030; PMCID: PMC9820408.
Huang Y, Jin M, Pi R, Zhang J, Chen M, Ouyang Y, Liu A, Chao X, Liu P, Liu J, Ramassamy C, Qin J. Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells. Neurosci Lett. 2013 Feb 22;535:146-51. doi: 10.1016/j.neulet.2012.12.051. Epub 2013 Jan 8. PMID: 23313590.
Wang Y, Wang Y, Li J, Hua L, Han B, Zhang Y, Yang X, Zeng Z, Bai H, Yin H, Lou J. Effects of caffeic acid on learning deficits in a model of Alzheimer's disease. Int J Mol Med. 2016 Sep;38(3):869-75. doi: 10.3892/ijmm.2016.2683. Epub 2016 Jul 18. PMID: 27430591.
Andrade S, Loureiro JA, Pereira MC. Caffeic acid for the prevention and treatment of Alzheimer's disease: The effect of lipid membranes on the inhibition of aggregation and disruption of Aβ fibrils. Int J Biol Macromol. 2021 Nov 1;190:853-861. doi: 10.1016/j.ijbiomac.2021.08.198. Epub 2021 Sep 2. PMID: 34480909.
Chang W, Huang D, Lo YM, Tee Q, Kuo P, Wu JS, Huang W, Shen S. Protective Effect of Caffeic Acid against Alzheimer's Disease Pathogenesis via Modulating Cerebral Insulin Signaling, β-Amyloid Accumulation, and Synaptic Plasticity in Hyperinsulinemic Rats. J Agric Food Chem. 2019 Jul 10;67(27):7684-7693. doi: 10.1021/acs.jafc.9b02078. Epub 2019 Jun 28. PMID: 31203623.
Nejabati HR, Roshangar L. Kaempferol as a potential neuroprotector in Alzheimer's disease. J Food Biochem. 2022 Dec;46(12):e14375. doi: 10.1111/jfbc.14375. Epub 2022 Aug 5. PMID: 35929364.
Dong X, Zhou S, Nao J. Kaempferol as a therapeutic agent in Alzheimer's disease: Evidence from preclinical studies. Ageing Res Rev. 2023 Jun;87:101910. doi: 10.1016/j.arr.2023.101910. Epub 2023 Mar 15. PMID: 36924572.
Jin S, Zhang L, Wang L. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine. Biomed Pharmacother. 2023 Sep;165:115215. doi: 10.1016/j.biopha.2023.115215. Epub 2023 Jul 24. PMID: 37494786.
Alexander C, Parsaee A, Vasefi M. Polyherbal and Multimodal Treatments: Kaempferol- and Quercetin-Rich Herbs Alleviate Symptoms of Alzheimer's Disease. Biology (Basel). 2023 Nov 20;12(11):1453. doi: 10.3390/biology12111453. PMID: 37998052; PMCID: PMC10669725.
Zhang Q, Yan Y. The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer's disease: a narrative review. Neural Regen Res. 2023 Dec;18(12):2582-2591. doi: 10.4103/1673-5374.373680. PMID: 37449593; PMCID: PMC10358679.
Leszek Jerzy, Alzheimer's Disease: Current State of Knowledge, Therapeutic Perspectives. „Polish Neurological Review”, 2012, Volume 8, Issue 3, pp. 101-106 [online], [access 29.03.2024]. (in Polish)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Katarzyna Madyniak, Piotr Ciecierski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 446
Number of citations: 0
